Exchange: NASDAQ·Updated 07:18 PM EDT
LUCD logo

LUCDLucid Diagnostics Inc

$1.08
$0.0973
(9.90%)
Today
Closed $1.08
$0.0013
(0.12%)
After Hours
EarningsAug 12
Mkt Cap$219.31M
Vol6.01M
News
all
press releases
Lucid Diagnostics Misses On Revenue, But 2026 Growth Outlook Lights Up Bull Case
Lucid Diagnostics reported Q1 revenue miss. Analyst significant expects revenue growth in 2026/27. Raises PT to $9.25.read more...
Benzinga
News Placeholder
More News
News Placeholder
Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results
Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results...
Yahoo! Finance: News
News Placeholder
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results PR Newswire NEW YORK, May 15, 2026...
PR Newswire
News Placeholder
Lucid Diagnostics Q1 Earnings Call Highlights
Lucid Diagnostics Q1 Earnings Call Highlights...
Yahoo! Finance: News
News Placeholder
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates
Lucid Diagnostics (LUCD) delivered earnings and revenue surprises of -40.00% and -10.29%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results PR Newswire NEW...
PR Newswire
News Placeholder
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates
Hyperfine (HYPR) delivered earnings and revenue surprises of 0.00% and +14.12%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Lucid Diagnostics Inc. (LUCD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Lucid Diagnostics (LUCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
News Placeholder
10x Genomics (TXG) Reports Q1 Loss, Beats Revenue Estimates
10x Genomics (TXG) delivered earnings and revenue surprises of +65.52% and +3.57%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates
LivaNova (LIVN) delivered earnings and revenue surprises of +15.29% and +3.60%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
<
1
2
...
>

Advertisement|Remove ads.